Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
cliniphar Ltd.

cliniphar Ltd. (432A.T) Stock Overview

Explore cliniphar Ltd.’s financial performance, market position, analyst ratings, and future outlook.

432A.T●JPX
HealthcareMedical - Pharmaceuticals
¥1450.00
¥0.00(0.00%)
Japanese Market opens in 17h 13m

cliniphar Ltd. (432A.T)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E RatioN/A
EPS (TTM)$190.24
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

432A.T Stock Analysis & Investment Overview (JPX)

Our AI-powered analysis of cliniphar Ltd. (JPX: 432A.T) gives investors deep insight into how the stock performs on the JPX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, cliniphar Ltd.'s JPX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of 432A.T on the JPX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the JPX listing.

Key metrics behind cliniphar Ltd.'s JPX-traded stock include a P/E ratio of N/A and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 432A.T on the JPX.

Price Performance (JPX: 432A.T)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://cliniphar.com
NaN
OMM Building, Osaka, OS, 540-0008

Company Facts

IPO DateOct 7, 2025
CountryJP
Actively Trading

Frequently Asked Questions